Korro Bio, Inc.(KRRO)

Biotechnology · Cambridge, MA

$9.71-0.26 (-2.61%)

Delayed quote: Oct 6, 2026, 2:05 PM EDT

EV/EBITDA Ratio: N/A

Basis: Current FMP quote-based enterprise value / four-quarter operating income plus matched D&A. Source: stored company filings and market data; unavailable inputs remain N/A.

The EV/EBITDA ratio is N/A as of 2026-10-06T18:08:17.277Z.

Stored calculation inputs

Calculation as of: 2026-10-06T18:08:17.277Z.

Quote observation: 2026-10-06T18:05:12.000Z. Amounts in USD. The price header may show a later quote.

Quote market capitalization: 96,647,194
Total debt · period ending 2026-06-30: 42,213,000
Cash · period ending 2026-06-30: 24,905,000
TTM operating EBITDA · period ending 2026-06-30: -73,093,000

FMP input reference: eea6c7d5cd6e3fe508f4e89a8ac0afa25f3437e05bd10ab9ad2dfceb562d4ef8

EV/Sales|P/E Ratio|EBITDA|All Metrics

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

KRRO EV/EBITDA Ratio Metrics

EV/EBITDA RATIO

N/A

KRRO Competitors' EV/EBITDA Ratio

KRRO

Korro Bio, Inc.

Current

Market Cap

$96.65M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

MIST

Milestone Pharmaceuticals Inc.

vs KRRO

Market Cap

$97.28M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CNXU

Conexeu Sciences Inc.

vs KRRO

Market Cap

$99.01M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

PYPD

PolyPid Ltd.

vs KRRO

Market Cap

$99.23M

EV/EBITDA Ratio

N/A

TTM Avg

57.81x

3Y Avg

57.81x

5Y Avg

8.19x

PARK

Park Dental Partners, Inc. Common Stock

vs KRRO

Market Cap

$92.33M

EV/EBITDA Ratio

N/A

TTM Avg

51.11x

3Y Avg

51.11x

5Y Avg

51.11x

BMEA

Biomea Fusion, Inc.

vs KRRO

Market Cap

$91.46M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

JYNT

The Joint Corp.

vs KRRO

Market Cap

$102.64M

EV/EBITDA Ratio

26.11x

TTM Avg

52.21x

3Y Avg

97.08x

5Y Avg

75.85x

Equillium, Inc.

vs KRRO

Market Cap

$90.41M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

RLYB

Rallybio Corporation

vs KRRO

Market Cap

$90.32M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

OKUR

OnKure Therapeutics, Inc.

vs KRRO

Market Cap

$103.06M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	EV/EBITDA RATIO	TTM	3Y	5Y
Korro Bio, Inc. (KRRO)	$96.65M	N/A	N/A	N/A	N/A
Milestone Pharmaceuticals Inc. (MIST)vs ›	$97.28M	N/A	N/A	N/A	N/A
Conexeu Sciences Inc. (CNXU)vs ›	$99.01M	N/A	N/A	N/A	N/A
PolyPid Ltd. (PYPD)vs ›	$99.23M	N/A	57.81x	57.81x	8.19x
Park Dental Partners, Inc. Common Stock (PARK)vs ›	$92.33M	N/A	51.11x	51.11x	51.11x
Biomea Fusion, Inc. (BMEA)vs ›	$91.46M	N/A	N/A	N/A	N/A
The Joint Corp. (JYNT)vs ›	$102.64M	26.11x	52.21x	97.08x	75.85x
Equillium, Inc. (EQ)vs ›	$90.41M	N/A	N/A	N/A	N/A
Rallybio Corporation (RLYB)vs ›	$90.32M	N/A	N/A	N/A	N/A
OnKure Therapeutics, Inc. (OKUR)vs ›	$103.06M	N/A	N/A	N/A	N/A

EV/EBITDA Ratio Formula & Definition

EV/EBITDA = Enterprise Value / EBITDA (TTM)

Enterprise value to EBITDA is a capital-structure-neutral valuation multiple, useful for comparing companies with different debt levels and tax rates.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Related Metrics

EV/Sales P/E Ratio EBITDA All Metrics